Atalante X — Class II medical device recall Z-1739-2025
Ongoing recall by WANDERCRAFT SAS, reported 2025-05-14, distributed in NY, PA. Potential for exoskeleton to lose lateral balance and cause patient to fall.
| Recall number | Z-1739-2025 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | WANDERCRAFT SAS, Paris, N/A, France |
| Recall initiated | 2025-04-03 |
| Classified | 2025-05-08 |
| Reported by FDA | 2025-05-14 |
| Distributed | NY, PA |
| Quantity | 3 |
| UPC / GTIN / UDI-DI | 03665965000129 |
Product
Atalante X, Powered Exoskeleton. Atalante X is intended to perform ambulatory functions and mobility exercises, hands-free, in rehabilitation institutions under the supervision of a trained operator.
Reason for recall
Potential for exoskeleton to lose lateral balance and cause patient to fall.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1739-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.